Genomma Lab (Mexico) Today
| LABB Stock | MXN 14.58 0.48 3.40% |
Performance2 of 100
| Odds Of DistressLess than 10
|
Genomma Lab is trading at 14.58 as of the 19th of April 2024; that is 3.40 percent increase since the beginning of the trading day. The stock's open price was 14.1. Genomma Lab has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Genomma Lab Internacional are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of May 2022 and ending today, the 19th of April 2024. Click here to learn more.
Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. Genomma Lab Internacional, S.A.B. The company has 1 B outstanding shares. More on Genomma Lab Internacional
Moving against Genomma Stock
| 0.71 | VALEN | Vale SA | PairCorr |
| 0.67 | AAPL | Apple Inc | PairCorr |
| 0.62 | BABAN | Alibaba Group Holding | PairCorr |
Genomma Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Genomma Lab's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Genomma Lab or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Maximo Juda |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Genomma Lab Internacional (LABB) is traded on Mexican Exchange in Mexico and employs 2,297 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 18.09 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genomma Lab's market, we take the total number of its shares issued and multiply it by Genomma Lab's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Genomma Lab Internacional operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 1 B outstanding shares.
Genomma Lab Internacional has accumulated about 1.41 B in cash with 1.47 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.4.
Check Genomma Lab Probability Of Bankruptcy
Ownership AllocationGenomma Lab secures a total of 1 Billion outstanding shares. Genomma Lab secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Genomma Ownership Details
Genomma Lab Internacional Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Genomma Lab market risk premium is the additional return an investor will receive from holding Genomma Lab long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Genomma Lab. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Genomma Lab's alpha and beta are two of the key measurements used to evaluate Genomma Lab's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.76 | |||
| Semi Deviation | 1.91 | |||
| Standard Deviation | 2.45 | |||
| Variance | 5.98 |
Genomma Stock Against Markets
Picking the right benchmark for Genomma Lab stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Genomma Lab stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Genomma Lab is critical whether you are bullish or bearish towards Genomma Lab Internacional at a given time. Please also check how Genomma Lab's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Genomma Lab without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Genomma Lab Corporate Directors
Genomma Lab corporate directors refer to members of a Genomma Lab board of directors. The board of directors generally takes responsibility for the Genomma Lab's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Genomma Lab's board members must vote for the resolution. The Genomma Lab board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Scott Emerson | Independent Director | Profile | |
| Marco Munoz | Non-Member Secretary of the Board of Directors | Profile | |
| Jorge Munoz | Independent Director | Profile | |
| Ignacio Rodriguez | Independent Director | Profile |
How to buy Genomma Stock?
Before investing in Genomma Lab, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Genomma Lab. To buy Genomma Lab stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Genomma Lab. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Genomma Lab stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Genomma Lab Internacional stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Genomma Lab Internacional stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Genomma Lab Internacional, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Genomma Lab Internacional?
The danger of trading Genomma Lab Internacional is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Genomma Lab is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Genomma Lab. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Genomma Lab Internacional is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Genomma Lab Internacional. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Genomma Stock analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Transaction History View history of all your transactions and understand their impact on performance |